Dextroamphetamine Sulfate



Dextroamphetamine Sulfate





(dex troe am fet’ a meen)

Dexedrine SpansuleDNC

PREGNANCY CATEGORY C

CONTROLLED SUBSTANCE C-II


Drug Classes

Amphetamine

CNS stimulant


Therapeutic Actions

Acts in the CNS to release norepinephrine from nerve terminals; in higher doses also releases dopamine; suppresses appetite; increases alertness, elevates mood; often improves physical performance, especially when fatigue and sleep deprivation have caused impairment; efficacy in hyperkinetic syndrome, ADHD in children appears paradoxical and is not understood.


Indications



  • Narcolepsy


  • Adjunct therapy for abnormal behavioral syndrome in children and adults (ADHD, hyperkinetic syndrome) that includes psychological, social, educational measures



  • Unlabeled uses: Cocaine-dependence treatment, autism, traumatic brain injury



Available Forms

Tablets—5, 10 mg; ER capsulesDNC—5, 10, 15 mg; oral solution—5 mg/mL


Dosages

Adults



  • Narcolepsy: Start with 10 mg/day PO in divided doses; increase in increments of 10 mg/day at weekly intervals. If insomnia or anorexia occurs, reduce dose. Usual dosage is 5–60 mg/day PO in divided doses. Give first dose on awakening, additional doses (one or two) every 4–6 hr; long-acting forms can be given once a day.


  • ADHD: 5 mg PO once or twice daily; may be increased at rate of 5 mg weekly to maximum dose of 40 mg/day.

Pediatric patients

Jul 20, 2016 | Posted by in NURSING | Comments Off on Dextroamphetamine Sulfate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access